Back
Open Access

GLADIATOR: The effects of geranylgeranylacetone in patients with HFpEF

Session: Hottest trials and trial updates (2)
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Speaker: Mr G. Voordes (Groningen, NL)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Gerhard Hendrik Dirk Voordes

University Medical Centre Groningen, Groningen (Netherlands (The))
2 presentations
0 follower

20 more presentations in this session

DIGIT­HF: Baseline characteristics compared to recent trials in heart failure with reduced ejection fraction

Speaker: Professor U. Bavendiek (Hannover, DE)

Access
Like
Thumbnail

Discussant review - DIGIT­HF

Speaker: Professor D. van Veldhuisen (Groningen, NL)

Access
Like
Thumbnail

Panel discussion - DIGIT­HF

Access
Like
Thumbnail

CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy

Speaker: Doctor A. Owens (Philadelphia, US)

Access
Like
Thumbnail

Discussant review - CIRRUS­HCM

Speaker: Professor I. Olivotto (Florence, IT)

Access
Like
Thumbnail

Access the full session

Hottest trials and trial updates (2)

Speakers: Mr G. Voordes, Professor U. Bavendiek, Professor D. van Veldhuisen, Doctor A. Owens, Professor I. Olivotto
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources